Purchase Order 75N93020P01353
Award Date 9/14/20
Potential Completion Date 4/1/21
Potential Value $622K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Boulder, CO 80301, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $208,050 firm-fixed-price purchase order to Somalogic Operating Co., Inc. for the procurement of 6 SomaScan 7K Assay kits and domestic shipping and handling services. The contract has a period of performance from September 8, 2023, to September 7, 2024, with delivery to Bethesda, MD. Somalogic, a commercial-stage proteomics company, provides the SomaScan platform, which uses...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a purchase order to Somalogic Operating Co., Inc. on May 15, 2026 for SomaScan assay kits valued at $522,030.00 under an 8(a) sole-source set-aside. The order covers 15 SomaScan 7K and 11K assay kits in multiple sample types (plasma, serum, urine, cerebrospinal fluid, and cell and tissue variants) to support the Center for Human Immunology's analysis of clinical samples across ongoing longitudinal studies and clinical...
- Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., has been awarded a $242,725 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. Under this contract, Somalogic will provide SomaScan 7K Assay kits for use in ongoing research analyzing clinical samples to study the immune system. Deliveries of the plasma, serum, urine, cerebral spinal fluid, cell and tissue...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., to provide SomaScan HTS assay kits for cell, tissue, human serum, and human plasma analysis. The $146,925 award supports proteomics research and clinical trials analyzing disease pathways and developing diagnostics. Somalogic is a...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1,501,831.62 firm fixed price purchase order to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc. This order is for SomaScan assay kits and reagents to be delivered by June 22, 2023. Somalogic is a commercial-stage proteomics company that provides protein biomarker discovery and diagnostic services through its proprietary SomaScan...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $554,800 firm fixed price purchase order to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc. The order is for Somalogic SomaScan 7K HTS Kits to support proteomic research projects at the Center for Human Immunology, Inflammation, and Autoimmunity. The kits will enable highly multiplexed analysis of over 7,000 proteins in various...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $312,075 firm fixed price purchase order to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc. of Boulder, Colorado. The procurement is for the purchase of nine Somalogic 7K HTS assay kits to support NIH research efforts. Somalogic will deliver the requested products as the prime contractor under this contract, which runs from...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $67,500 firm-fixed-price purchase order to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc. The contract is for the provision of SomaScan Discovery services delivering 7,000-protein measurements and domestic shipping and handling to Bethesda, Maryland. The solicitation sought these services to support research aimed...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., for SomaScan 7K assay kits. The potential value of the contract is $208,050.00, and the period of performance runs through April 12, 2024. This sole-source award was made under the authority of FAR 13.106-1(b) for commercial items, as...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $245,000.00 firm fixed price purchase order to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., for analysis using SomaScan assays. This is a commercial-stage proteomics company that provides protein biomarker discovery and diagnostic services through its proprietary SomaScan platform. The contract has no set-aside...
The National Institute of Allergy and Infectious Diseases awarded a purchase order to Somalogic Operating Co., Inc. on September 14, 2020, for SomaScan HTS 1.3K assay kits and reagents for proteomic analysis, with a ceiling value of $621,791.72. Performance is located in Boulder, Colorado. The order carries a firm fixed price structure with an ultimate completion date of April 1, 2021.
Generated 6/1/26, 10:51 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $621.8k | 9/13/20 |